Funded by Mark Zuckerberg and Sergiy Brin, the $3 million individual prizes are the richest in science.

It tracks biomarkers to detect cancers and monitor drug delivery.

And it's verily dedicated to understanding diseases better.

The health-focused division of Google (Alphabet) is teaming up with a pharmaceutical company for another diabetes monitor.

Google's Life Sciences division - now a subsidiary of Alphabet - is working with DexCom to build tiny, bandage-sized sensors to track glucose levels. The slap-on monitoring system could replace finger sticks for diabetics over the next few of years.